yahoo_financeOriginal article
Curis shares surge after updated emavusertib data strengthens clinical outlook (NASDAQ:CRIS)
Data ReadoutpositiveemavusertibPositive
AI Analysis
Summary
Curis shares surged following the release of updated clinical data for emavusertib that strengthened the company's clinical development outlook.
Outcome Details
Updated emavusertib data strengthens clinical outlook
Importance:6/10
Sentiment:
0.75
clinical datastock movementemavusertib
Related Companies
Read the original article
Published by yahoo_finance on July 22, 2026 12:25 PM